文献速递胸部CT

多中心纵向研究中同时校正容积、噪声与扫描仪偏倚的CT肺气肿进展定量

Quantification of Emphysema Progression at CT Using Simultaneous Volume, Noise, and Bias Lung Density Correction.
PubMed 文献 · Radiology · 2024-01-01

基于COPDGene前瞻性研究的二次分析,纳入4954名完成基线与5年随访的受试者,比较容积校正肺密度(VALD)与同时校正容积-噪声-偏倚的肺密度(VNB-ALD)在肺气肿进展评估中的表现。VNB-ALD重复性系数更低(14 g/L vs 30 g/L),与视觉评分一致,能区分进展者与非进展者,且进展者FEV1年下降更多(-42 mL/年 vs -32 mL/年)。

要点

  • VNB-ALD重复性系数为14 g/L,优于VALD的30 g/L。
  • VNB-ALD与视觉评分一致,可区分肺气肿进展者与非进展者。
  • VNB-ALD进展者FEV1年下降更多(-42 mL/年 vs -32 mL/年)。

核心结论

  • 同时校正容积、噪声和扫描仪偏倚的肺密度变化估计提高了重复性分析,与视觉读数一致,能区分进展者与非进展者,并与肺功能指标更大下降相关。

研究设计与样本

  • COPDGene前瞻性研究的二次分析,纳入4954名完成基线和5年随访的受试者(平均年龄60岁±9[SD],2511男,2443女),其中1329名在随访时进行了重复低剂量采集;比较VALD与VNB-ALD,并对102名随机选择的受试者进行视觉评分。

诊断标准与关键数值

  • 平均重复性系数:VALD为30 g/L±0.46,VNB-ALD为14 g/L±0.34。
  • 非进展者与进展者的VALD均值分别为-5.5 g/L±9.5与-8.6 g/L±9.6,差异无统计学意义(P=.11)。
  • 非进展者与进展者的VNB-ALD均值分别为-0.67 g/L±4.8与-4.2 g/L±5.5,差异有统计学意义(P<.001)。
  • VNB-ALD进展者FEV1年下降-42 mL/年,非进展者为-32 mL/年(Tukey校正P=.002)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background CT attenuation is affected by lung volume, dosage, and scanner bias, leading to inaccurate emphysema progression measurements in multicenter studies. Purpose To develop and validate a method that simultaneously corrects volume, noise, and interscanner bias for lung density change estimation in emphysema progression at CT in a longitudinal multicenter study. Materials and Methods In this secondary analysis of the prospective Genetic Epidemiology of Chronic Obstructive Pulmonary Disease (COPDGene) study, lung function data were obtained from participants who completed baseline and 5-year follow-up visits from January 2008 to August 2017. CT emphysema progression was measured with volume-adjusted lung density (VALD) and compared with the joint volume-noise-bias-adjusted lung density (VNB-ALD). Reproducibility was studied under change of dosage protocol and scanner model with repeated acquisitions. Emphysema progression was visually scored in 102 randomly selected participants. A stratified analysis of clinical characteristics was performed that considered groups based on their combined lung density change measured by VALD and VNB-ALD. Results A total of 4954 COPDGene participants (mean age, 60 years ± 9 [SD]; 2511 male, 2443 female) were analyzed (1329 with repeated reduced-dose acquisition in the follow-up visit). Mean repeatability coefficients were 30 g/L ± 0.46 for VALD and 14 g/L ± 0.34 for VNB-ALD. VALD measurements showed no evidence of differences between nonprogressors and progressors (mean, -5.5 g/L ± 9.5 vs -8.6 g/L ± 9.6; P = .11), while VNB-ALD agreed with visual readings and showed a difference (mean, -0.67 g/L ± 4.8 vs -4.2 g/L ± 5.5; P < .001). Analysis of progression showed that VNB-ALD progressors had a greater decline in forced expiratory volume in 1 second (-42 mL per year vs -32 mL per year; Tukey-adjusted P = .002). Conclusion Simultaneously correcting volume, noise, and interscanner bias for lung density change estimation in emphysema progression at CT improved repeatability analyses and agreed with visual readings. It distinguished between progressors and nonprogressors and was associated with a greater decline in lung function metrics. Clinical trial registration no. NCT00608764 © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Goo in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Vegas Sánchez-Ferrero G, Díaz AA, Ash SY, et al. Quantification of Emphysema Progression at CT Using Simultaneous Volume, Noise, and Bias Lung Density Correction. Radiology. 2024. PMID: 38165244. doi:10.1148/radiol.231632

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。